AlphaCrest Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$12.5M |
| 2 |
Eli Lilly
LLY
|
+$8.08M |
| 3 |
Progressive
PGR
|
+$6.61M |
| 4 |
Altria Group
MO
|
+$5.83M |
| 5 |
Mastercard
MA
|
+$5.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$7.02M |
| 2 |
Toronto Dominion Bank
TD
|
+$6.13M |
| 3 |
US Bancorp
USB
|
+$5.09M |
| 4 |
Coca-Cola
KO
|
+$3.73M |
| 5 |
Medtronic
MDT
|
+$3.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.61% |
| 2 | Financials | 15.48% |
| 3 | Industrials | 12.41% |
| 4 | Consumer Discretionary | 11.91% |
| 5 | Healthcare | 11.71% |
Similar funds
AlphaCrest Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, AlphaCrest Capital Management held 1,206 positions worth $1.16B, up 75% from $659M the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
AlphaCrest Capital Management deployed $496M of net new capital in Q2 2019, opening 410 new positions and adding to 366 existing holdings. Its largest new stake was Progressive: 85,511 shares worth $6.83M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was CME Group, an estimated $7.02M trimmed.
- AlphaCrest Capital Management's largest Q2 2019 buy was Progressive: 85,511 shares worth $6.83M.
- AlphaCrest Capital Management added most to Cisco in Q2 2019, an estimated $12.5M increase.
- AlphaCrest Capital Management's biggest Q2 2019 reduction was CME Group, cutting an estimated $7.02M.
- AlphaCrest Capital Management fully exited Toronto Dominion Bank in Q2 2019, selling an estimated $6.13M.
- AlphaCrest Capital Management's ten largest holdings make up 6.3% of its $1.16B portfolio in Q2 2019.
- AlphaCrest Capital Management opened 410 new positions and closed 208 in Q2 2019.
- AlphaCrest Capital Management's portfolio value rose 75% quarter-over-quarter to $1.16B.
Based on AlphaCrest Capital Management's 13F filing for Q2 2019, filed 12 Aug 2019.